The ASC 606 transition: Determining the transaction price
As a result, the licence cannot be purchased separately from the manufacturing services. An entity, a pharmaceutical company, licenses to a customer its patent rights to an approved drug compound for 10 years and also promises to manufacture the drug for the customer. The drug is a mature product; therefore the entity will not undertake […]